Navigation Links
FDAnews Special Subscription Offer for Devices & Diagnostics Letter
Date:8/25/2014

Falls Church, VA (PRWEB) August 25, 2014

Subscribe to Devices & Diagnostics Letter
http://www.fdanews.com/DDLPR

510(k) Guidance Overhauls Agency Risk vs. Benefit Review
For the first time, manufacturers submitting 510(k)s would have to show FDA reviewers that the risks and benefits of a candidate device are acceptable and substantially equivalent to those of the predicate device, according to draft guidance issued last week.

Manufacturers should be able to demonstrate the likelihood that a risk or beneficial effect will occur and how widely it will occur, the FDA says. For example, a modified device may cause a benefit in only a few patients, or broadly across the patient population, and a specific risk may be rare or common. Those situations would raise different considerations in reviewing a 510(k) submission, the agency adds...

About Devices & Diagnostics Letter
For more than 40 years, Devices & Diagnostics Letter has been a must-read for industry leaders eager to stay in compliance with the FDA.

With 50 issues a year, readers can be confident that they'll stay abreast of the latest FDA regulations because each bi-weekly issue brings the latest regulatory news including:

  •     UDI implementation to cybersecurity
  •     The medical device excise tax
  •     EU device regulations

Plus, each issue is filled with links to draft and final guidances, proposed and final rules, texts of proposed legislation and GAO reports and many others.

Subscribe Today
Order NOW and pay just $947, a savings of $300 of the regular one-year price pf $1,247.

EASY WAYS TO ORDER
Online:     http:// http://www.fdanews.com/DDLPR
By phone: 888-838-5578 or 703-538-7600
Fax:         703-538-7676
Mail to:     FDAnews
                300 N Washington St
                Ste 200
                Falls Church VA USA 22046-3431

100% Money-Back Guarantee. FDAnews' ironclad guarantee ensures satisfaction. If at any time during the one-year subscription the subscriber become dissatisfied, they may cancel and receive a full refund. No questions asked.

ABOUT FDANEWS
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Read the full story at http://www.prweb.com/releases/FDAnews/DDLPR/prweb12116394.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. FDAnews Announces The FDA Unique Device Identification (UDI) Rule Virtual Conference
2. FDAnews Management Report: Managing Contract Manufacturers and Testing Labs
3. FDAnews Management Report: Implementing Risk-Based Verification and Validation
4. FDAnews Announces CDRH’s Office of Compliance Reorganization: A “One-On-One” with Office Director Steve Silverman, Webinar, Feb. 5, 2014
5. FDAnews Announces Device Software Verification and Validation: Get Ready for a New Breed of Investigators, On-Demand Webinar, Aug. 12, 2014
6. FDAnews Announces — Improving Your FDA Import Success Rate: Tips for Thinking Ahead of the FDAWebinar, Aug. 7, 2014
7. FDAnews Announces — Choosing the Right Drug Name: How to Increase Your Chances for Approval Webinar, July 22, 2014
8. FDAnews Announces — New Job Board Now Available on FDAnews.com
9. FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC
10. FDAnews New Workshop, 2 Weeks to Register — Innovative Process Validation Strategies for Medical Devices, Aug. 26-27, 2014, Bethesda, MD
11. FDAnews Announces Choosing the Best Device Sample Size for Verification and Validation: Tools to Safely Speed Your Device to Market, On-Demand Webinar, Aug. 27, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 23, 2017 , ... News Advisory/Interview Opportunity , After six years of advocacy, ... in Europe for public health and the environment and is calling on the United ... and the overwhelming support of European citizens, the European Union (EU) will, beginning next ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ogden Clinic, the largest multi-specialty ... payment system, to expand its focus on patient care by providing an advanced ... , “At Ogden Clinic, we are working to become a different type of ...
(Date:3/23/2017)... ... March 23, 2017 , ... Vortex ... of “Profiling protein expression in circulating tumor cells using microfluidic western blotting” in ... of the Vortex technology to capture CTCs and a microfluidic single-CTC ...
(Date:3/22/2017)... ... 22, 2017 , ... Sam & Associates Insurance Agency, a ... related services to residents of the region, is embarking on a charity effort ... wild lands. , Endangered Species International is committed to ending the anthropogenic trends ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... consuming and frustrating and this tool bypasses that. Healthcare facilities across the ... an opportunity to offer their clients and hospitals, across the country, an efficient ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... NEW YORK , March 22, 2017 ... ... cannabis market was worth an estimated $6.6 billion in 2016, and ... of 16% or reaching more than $24 billion by 2025. The ... 2025, or growing from $4.7 billion in 2016, to an estimated ...
(Date:3/22/2017)... 22, 2017 FinancialBuzz.com News Commentary ... rapidly due to the significant development and innovation in ... Market Research, the global electrophysiology market was worth $3.42 ... billion by 2022, with a GAGR of 13.4%. Electrophysiology ... diagnose abnormal heartbeats or arrhythmia. The report indicates that ...
(Date:3/22/2017)... MAPLE GROVE, Minn. , March 22, 2017   ... of Clomipramine Hydrochloride Capsules* USP, 25 mg, 50 mg and ... (clomipramine hydrochloride) Capsules USP. The clomipramine ... for the 12 months ending December 2016, according to IMS ... ...
Breaking Medicine Technology: